MCMedicalCodingSoftware
J7519

J7519: Injection, mycophenolate mofetil, 10 mg

HCPCSTerminatedBETOS O1E

J7519 is a HCPCS Level II code for injection, mycophenolate mofetil, 10 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2026 and is not valid on new claims.

This code has been terminated

CMS terminated J7519 on September 30, 2026. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits: units per day

The most units of J7519 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
500 units
MAI 3: Date of Service Edit: Clinical · CMS Policy
outpatient
500 units
MAI 3: Date of Service Edit: Clinical · CMS Policy
DME supplier
500 units
MAI 3: Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for J7519

Long descriptor
Injection, mycophenolate mofetil, 10 mg

The official wording. This is what the code means.

Short descriptor
Inj. mycophenolate mofetil

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2023

When CMS introduced the code.

Terminated
September 30, 2026

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J7519

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J7519 is not quite right, the correct code is very often within a few positions of it.

  • J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
  • J7512Prednisone, immediate release or delayed release, oral, 1 mg
  • J7513Daclizumab, parenteral, 25 mgterminated
  • J7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mgterminated
  • J7515Cyclosporine, oral, 25 mg
  • J7516Injection, cyclosporine, 250 mg
  • J7517Mycophenolate mofetil, oral, 250 mgterminated
  • J7518Mycophenolic acid, oral, 180 mg
  • J7520Sirolimus, oral, 1 mg
  • J7521Tacrolimus, granules, oral suspension, 0.1 mg
  • J7524Mycophenolate mofetil, oral, 5 mg
  • J7525Tacrolimus, parenteral, 5 mg
  • J7526Injection, mycophenolate mofetil, 5 mg
  • J7527Everolimus, oral, 0.25 mg
  • J7528Mycophenolate mofetil, for suspension, oral, 100 mgterminated
  • J7529Mycophenolate mofetil, for suspension, oral, 5 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026